Interleukin-2-responsive wound-infiltrating lymphocytes in surgical adjuvant cancer immunotherapy.

Dubinett, S M

Interleukin-2-responsive wound-infiltrating lymphocytes in surgical adjuvant cancer immunotherapy. [electronic resource] - Immunological investigations Feb 1993 - 13-23 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

0882-0139

10.3109/08820139309066190 doi


Animals
Carcinoma--pathology
Cell Adhesion--drug effects
Cytotoxicity, Immunologic--drug effects
Female
Immunologic Factors--pharmacology
Immunotherapy
Inflammation
Interleukin-2--pharmacology
Killer Cells, Lymphokine-Activated--immunology
Mice
Mice, Inbred C3H
Mice, Inbred C57BL
Neoplasm Transplantation
Recombinant Proteins--pharmacology
Sarcoma, Experimental--pathology
Specific Pathogen-Free Organisms
T-Lymphocyte Subsets--drug effects